Chemoinformaics analysis of cyclobutyl heptyl ester
| Molecular Weight | 242.315 | nRot | 7 |
| Heavy Atom Molecular Weight | 220.139 | nRig | 6 |
| Exact Molecular Weight | 242.152 | nRing | 1 |
| Solubility: LogS | -3.942 | nHRing | 0 |
| Solubility: LogP | 4.071 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 39.5874 |
| nHD | 0 | BPOL | 27.2786 |
| QED | 0.391 |
| Synth | 2.14 |
| Natural Product Likeliness | 0.54 |
| NR-PPAR-gamma | 0.586 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.902 |
| Pgp-sub | 0 |
| HIA | 0.002 |
| CACO-2 | -4.561 |
| MDCK | 0.0000355 |
| BBB | 0.22 |
| PPB | 0.950802 |
| VDSS | 0.667 |
| FU | 0.0304073 |
| CYP1A2-inh | 0.553 |
| CYP1A2-sub | 0.309 |
| CYP2c19-inh | 0.759 |
| CYP2c19-sub | 0.067 |
| CYP2c9-inh | 0.579 |
| CYP2c9-sub | 0.5 |
| CYP2d6-inh | 0.082 |
| CYP2d6-sub | 0.059 |
| CYP3a4-inh | 0.388 |
| CYP3a4-sub | 0.134 |
| CL | 10.432 |
| T12 | 0.285 |
| hERG | 0.101 |
| Ames | 0.006 |
| ROA | 0.006 |
| SkinSen | 0.938 |
| Carcinogencity | 0.114 |
| EI | 0.988 |
| Respiratory | 0.212 |
| NR-Aromatase | 0.169 |
| Antiviral | Yes |
| Prediction | 0.711205 |